Xiao Changchun, Calado Dinis Pedro, Galler Gunther, Thai To-Ha, Patterson Heide Christine, Wang Jing, Rajewsky Nikolaus, Bender Timothy P, Rajewsky Klaus
The CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115, USA.
Cell. 2007 Oct 5;131(1):146-59. doi: 10.1016/j.cell.2007.07.021.
MiR-150 is a microRNA (miRNA) specifically expressed in mature lymphocytes, but not their progenitors. A top predicted target of miR-150 is c-Myb, a transcription factor controlling multiple steps of lymphocyte development. Combining loss- and gain-of-function gene targeting approaches for miR-150 with conditional and partial ablation of c-Myb, we show that miR-150 indeed controls c-Myb expression in vivo in a dose-dependent manner over a narrow range of miRNA and c-Myb concentrations and that this dramatically affects lymphocyte development and response. Our results identify a key transcription factor as a critical target of a stage-specifically expressed miRNA in lymphocytes and suggest that this and perhaps other miRNAs have evolved to control the expression of just a few critical target proteins in particular cellular contexts.
MiR-150是一种在成熟淋巴细胞而非其祖细胞中特异性表达的微小RNA(miRNA)。miR-150的一个顶级预测靶标是c-Myb,它是一种控制淋巴细胞发育多个步骤的转录因子。通过将针对miR-150的功能缺失和功能获得基因靶向方法与c-Myb的条件性和部分消融相结合,我们表明miR-150确实在体内以剂量依赖的方式在狭窄的miRNA和c-Myb浓度范围内控制c-Myb的表达,并且这会显著影响淋巴细胞的发育和反应。我们的结果确定了一种关键转录因子是淋巴细胞中阶段特异性表达的miRNA的关键靶标,并表明这种以及其他可能的miRNA已经进化为在特定细胞环境中控制仅少数关键靶蛋白的表达。